According to the data released by Iran Ministry of Health, a total of 27041 People Living With HIV had been registered in Iran by September 2013; with 89.3% of them being men and 10.7% women. Furthermore, 5118 of these cases have entered AIDS stage and 5471 have died.
Antiretroviral therapy can help to prevent people living with HIV from dying of AIDS and from developing tuberculosis, becoming ill and transmitting tuberculosis and HIV. Emerging science indicates that people should start HIV treatment earlier to realize these benefits.
Risk of HIV - AIDS in developing countries is increasing, While developed countries are somewhat able to control it through increasing awareness of this disease
HIV is from the family retroviruses, specifically a lentivirus. It contains RNA instead of DNA. HIV inserts its RNA into the CD4 cell (T-cell) and converts RNA into DNA. HIV then insets this DNA into human genes and HIV production begins. The now infected CD4 cell becomes an HIV producing factory.
Affiliation:Shiraz HIV/AIDS Research Center, Institute of Health, Shiraz University of Medical Sciences, Shiraz, Iran
Shiraz HIV/AIDS Research Center (SHARC) is an academic center, established in November 2009 in Shiraz, Iran and affiliated with Shiraz University of Medical Sciences (SUMS). This center benefits from the experiences of the capable faculty members and experts in HIV/AIDS related issues to make effective policies in health system and community. SHARC supports and funds scientific research projects, those which can lead to HIV/AIDS related policies and strategies for regional and national health sectors. Holding international and national workshops and congresses have been taken into account as one of the main duties of Shiraz HIV/AIDS Research Center. SHARC works on different fields of HIV/AIDS such as basic, clinical and preventive research with specific focus on behavioral & psychosocial aspects.
Shiraz Univesity of Medical Sciences
